Benzinga | Mar 2, 2021 07:22AM EST

Antares Pharma Q4 EPS $0.03, Inline, Sales $44.13M Beat $40.75M Estimate

Antares Pharma (NASDAQ:ATRS) reported quarterly earnings of $0.03 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $44.13 million which beat the analyst consensus estimate of $40.75 million by 8.30 percent. This is a 16.63 percent increase over sales of $37.84 million the same period last year.